Quantcast
Channel: Endpoints News
Viewing all articles
Browse latest Browse all 3455

Theriva’s oncolytic virus succeeds in pancreatic cancer study, but stock falls

$
0
0
Theriva Biologics' experimental oncolytic virus treatment and chemotherapy helped patients in a mid-stage study stay alive longer than chemotherapy alone. The company said Wednesday that the Phase 2b study included 96 ...

Viewing all articles
Browse latest Browse all 3455

Trending Articles